Thursday 10 December 2020

Rhizen Pharmaceuticals announces USFDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection



source https://www.pharmatutor.org/pharma-news/2020/rhizen-pharmaceuticals-announces-usfda-acceptance-of-its-ind-application-for-rp7214-in-sars-cov-2-infection
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...